U.S. Capital Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
U.S. Capital Wealth Advisors's LLY Position: Q1 2026 in Review
U.S. Capital Wealth Advisors increased its Eli Lilly (LLY) stake by 103% in Q1 2026, buying an estimated $8.99M and bringing the position to 17,474 shares worth $16.1M. The position accounts for 0.4% of the portfolio, ranked #56.
U.S. Capital Wealth Advisors first reported a position in LLY in Q3 2021 and has held it in 19 quarters since. 4,380 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- U.S. Capital Wealth Advisors held 17,474 shares of Eli Lilly worth $16.1M as of Q1 2026.
- U.S. Capital Wealth Advisors bought 8,863 Eli Lilly shares in Q1 2026, an estimated $8.99M.
- Eli Lilly made up 0.4% of U.S. Capital Wealth Advisors's portfolio in Q1 2026, its #56 holding.
- U.S. Capital Wealth Advisors first reported a position in Eli Lilly in Q3 2021 and has held it in 19 quarters since.
- 4,380 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.